

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.70061330 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.70061330 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.31844186 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22942516 |
| 5 | response to peptidoglycan (GO:0032494) | 3.97540470 |
| 6 | detection of other organism (GO:0098543) | 3.86122064 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 3.80494413 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.78893364 |
| 9 | positive thymic T cell selection (GO:0045059) | 3.77195634 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69574532 |
| 11 | detection of bacterium (GO:0016045) | 3.68808341 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 3.55351674 |
| 13 | positive regulation of histone deacetylation (GO:0031065) | 3.49470678 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.42886905 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42001425 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.41965913 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41965913 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40894669 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39833904 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.36559464 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.33546879 |
| 22 | germinal center formation (GO:0002467) | 3.32626450 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.31911108 |
| 24 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.29216205 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28459152 |
| 26 | thymic T cell selection (GO:0045061) | 3.22623573 |
| 27 | negative T cell selection (GO:0043383) | 3.17771984 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.14958858 |
| 29 | leukocyte aggregation (GO:0070486) | 3.10260523 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 3.07116961 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.06554504 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05297872 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04013085 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03617724 |
| 35 | protein localization to endosome (GO:0036010) | 3.00863981 |
| 36 | positive T cell selection (GO:0043368) | 3.00557036 |
| 37 | response to host immune response (GO:0052572) | 2.98802078 |
| 38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.98802078 |
| 39 | T-helper 1 type immune response (GO:0042088) | 2.98002555 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95926498 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 2.93453598 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92690428 |
| 43 | response to host (GO:0075136) | 2.92690428 |
| 44 | response to host defenses (GO:0052200) | 2.92690428 |
| 45 | myeloid dendritic cell differentiation (GO:0043011) | 2.91029907 |
| 46 | T cell selection (GO:0045058) | 2.87581771 |
| 47 | detection of biotic stimulus (GO:0009595) | 2.86701793 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83455053 |
| 49 | defense response to protozoan (GO:0042832) | 2.80534579 |
| 50 | tolerance induction (GO:0002507) | 2.79320863 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 2.77631924 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76824515 |
| 53 | B cell homeostasis (GO:0001782) | 2.75822960 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75677030 |
| 55 | hepatocyte apoptotic process (GO:0097284) | 2.73303248 |
| 56 | response to protozoan (GO:0001562) | 2.72333607 |
| 57 | cellular response to zinc ion (GO:0071294) | 2.72104177 |
| 58 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71703348 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 2.71703348 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71703348 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71703348 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71703348 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 2.71703348 |
| 64 | regulation of necroptotic process (GO:0060544) | 2.70705545 |
| 65 | cytidine catabolic process (GO:0006216) | 2.69815674 |
| 66 | cytidine deamination (GO:0009972) | 2.69815674 |
| 67 | cytidine metabolic process (GO:0046087) | 2.69815674 |
| 68 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68960285 |
| 69 | cellular response to growth hormone stimulus (GO:0071378) | 2.64604506 |
| 70 | B cell mediated immunity (GO:0019724) | 2.64281698 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63963041 |
| 72 | myeloid cell activation involved in immune response (GO:0002275) | 2.63158783 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 2.62954917 |
| 74 | T cell migration (GO:0072678) | 2.61505920 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60638805 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59942463 |
| 77 | positive regulation of type 2 immune response (GO:0002830) | 2.58596296 |
| 78 | macrophage activation (GO:0042116) | 2.57757291 |
| 79 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.56699183 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.56113007 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.56085256 |
| 82 | positive regulation of lamellipodium assembly (GO:0010592) | 2.54475389 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.54396608 |
| 84 | cellular response to interferon-gamma (GO:0071346) | 2.53970020 |
| 85 | desmosome organization (GO:0002934) | 2.53935150 |
| 86 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52515436 |
| 87 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.52390744 |
| 88 | response to type I interferon (GO:0034340) | 2.52247498 |
| 89 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51614022 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51453477 |
| 91 | response to interleukin-15 (GO:0070672) | 2.50354906 |
| 92 | establishment of endothelial barrier (GO:0061028) | 2.49520892 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 2.48678953 |
| 94 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.48538978 |
| 95 | microglial cell activation (GO:0001774) | 2.47725400 |
| 96 | positive regulation of p38MAPK cascade (GO:1900745) | 2.46956303 |
| 97 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.46218532 |
| 98 | regulation of macrophage cytokine production (GO:0010935) | 2.46205008 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 2.45739370 |
| 100 | Golgi transport vesicle coating (GO:0048200) | 2.45739370 |
| 101 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.45495110 |
| 102 | positive regulation of interferon-alpha production (GO:0032727) | 2.45237915 |
| 103 | sequestering of metal ion (GO:0051238) | 2.43535435 |
| 104 | positive regulation of protein deacetylation (GO:0090312) | 2.43508926 |
| 105 | T cell costimulation (GO:0031295) | 2.43181615 |
| 106 | pinocytosis (GO:0006907) | 2.42795447 |
| 107 | hemidesmosome assembly (GO:0031581) | 2.41070641 |
| 108 | type I interferon signaling pathway (GO:0060337) | 2.41001182 |
| 109 | cellular response to type I interferon (GO:0071357) | 2.41001182 |
| 110 | regulation of B cell differentiation (GO:0045577) | 2.39979908 |
| 111 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39632742 |
| 112 | regulation of interferon-alpha production (GO:0032647) | 2.38545800 |
| 113 | negative regulation of bone resorption (GO:0045779) | 2.37601944 |
| 114 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.36899572 |
| 115 | lymphocyte costimulation (GO:0031294) | 2.36562986 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36327378 |
| 117 | neutrophil activation involved in immune response (GO:0002283) | 2.35497694 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.35325435 |
| 119 | interferon-gamma production (GO:0032609) | 2.34846081 |
| 120 | low-density lipoprotein particle clearance (GO:0034383) | 2.34570578 |
| 121 | B cell receptor signaling pathway (GO:0050853) | 2.30987181 |
| 122 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.30784850 |
| 123 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.29588059 |
| 124 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29522919 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 2.28922671 |
| 126 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.28737653 |
| 127 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24343924 |
| 128 | positive regulation of isotype switching (GO:0045830) | 2.23004798 |
| 129 | regulation of cholesterol storage (GO:0010885) | 2.22753213 |
| 130 | response to laminar fluid shear stress (GO:0034616) | 2.22502431 |
| 131 | regulation of tolerance induction (GO:0002643) | 2.20403149 |
| 132 | negative regulation of stress fiber assembly (GO:0051497) | 2.19998629 |
| 133 | positive regulation of macrophage differentiation (GO:0045651) | 2.19938697 |
| 134 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19507036 |
| 135 | regulation of response to interferon-gamma (GO:0060330) | 2.19441648 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.18900855 |
| 137 | cellular extravasation (GO:0045123) | 2.18533795 |
| 138 | actin nucleation (GO:0045010) | 2.16797198 |
| 139 | neutrophil activation (GO:0042119) | 2.16537862 |
| 140 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.15035920 |
| 141 | granulocyte activation (GO:0036230) | 2.14736611 |
| 142 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.13156866 |
| 143 | valine metabolic process (GO:0006573) | 2.12030763 |
| 144 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.11596601 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.11524869 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.11522596 |
| 147 | positive regulation of tolerance induction (GO:0002645) | 2.10805651 |
| 148 | negative regulation of phagocytosis (GO:0050765) | 2.10598148 |
| 149 | positive regulation of nuclease activity (GO:0032075) | 2.10273684 |
| 150 | regulation of hypersensitivity (GO:0002883) | 2.09578771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24108882 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94980874 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72047176 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.34276348 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.31399832 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61169288 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53595903 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44327021 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.42534289 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38854120 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37167388 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36652591 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34186924 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32015648 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.30934718 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26905435 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19566415 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19441269 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.19086027 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18505195 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.15881781 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.15146140 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.13654741 |
| 24 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.07979728 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06656268 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05986326 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04223162 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93272664 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90833855 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90143185 |
| 31 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88383685 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84136746 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.82060034 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.81997321 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81066428 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79841268 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78967493 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78407268 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78052327 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76479411 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69799177 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68246529 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68174430 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68129339 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61663583 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60455696 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59126001 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58565114 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57965703 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56264761 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55574713 |
| 52 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55220477 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54038035 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53459160 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51747051 |
| 56 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49951996 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48394214 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46321831 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41705996 |
| 60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40232508 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37460947 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36418047 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35788977 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31626349 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31253377 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28786129 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27393968 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26470498 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25577994 |
| 70 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25327211 |
| 71 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24558577 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24273944 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22047984 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 1.21516285 |
| 75 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20858833 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20837784 |
| 77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20484204 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19574159 |
| 79 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19157614 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17929544 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17838005 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16424534 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16389925 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16192419 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12851167 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12172432 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11919073 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11663383 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11142766 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05991019 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05763698 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05600213 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05436032 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04942764 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04233920 |
| 96 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04068775 |
| 97 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04068775 |
| 98 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04054631 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04054631 |
| 100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03995446 |
| 101 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03908193 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03405710 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02167581 |
| 104 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01831232 |
| 105 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.01688878 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01296703 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00004822 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99822164 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99435288 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97462979 |
| 111 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96532206 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95002676 |
| 113 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93997688 |
| 114 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93134937 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92233761 |
| 116 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90738793 |
| 117 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88622005 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88025829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.36895464 |
| 2 | MP0000685_abnormal_immune_system | 2.52288306 |
| 3 | MP0003303_peritoneal_inflammation | 2.45173665 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.34403927 |
| 5 | MP0003436_decreased_susceptibility_to | 2.32296133 |
| 6 | MP0001790_abnormal_immune_system | 2.25053672 |
| 7 | MP0005387_immune_system_phenotype | 2.25053672 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.18398673 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.15692449 |
| 10 | MP0004947_skin_inflammation | 2.04388533 |
| 11 | MP0001800_abnormal_humoral_immune | 2.03811775 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.03535327 |
| 13 | MP0005451_abnormal_body_composition | 2.02018161 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 1.98041226 |
| 15 | MP0005000_abnormal_immune_tolerance | 1.97141644 |
| 16 | MP0005671_abnormal_response_to | 1.94836519 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.91639365 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.88314646 |
| 19 | MP0009785_altered_susceptibility_to | 1.81845004 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.77639020 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.76221711 |
| 22 | MP0005025_abnormal_response_to | 1.74053006 |
| 23 | MP0006054_spinal_hemorrhage | 1.73411973 |
| 24 | MP0002723_abnormal_immune_serum | 1.72129546 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.69783992 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.66074001 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.65476207 |
| 28 | MP0001819_abnormal_immune_cell | 1.64042915 |
| 29 | MP0003724_increased_susceptibility_to | 1.62931890 |
| 30 | MP0006082_CNS_inflammation | 1.59932619 |
| 31 | MP0002419_abnormal_innate_immunity | 1.59517571 |
| 32 | MP0002006_tumorigenesis | 1.53358836 |
| 33 | MP0008260_abnormal_autophagy | 1.52137957 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.51755594 |
| 35 | MP0002405_respiratory_system_inflammati | 1.50233598 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.48982834 |
| 37 | MP0004510_myositis | 1.48979612 |
| 38 | MP0002398_abnormal_bone_marrow | 1.46112783 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.43953080 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.42549874 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.40053858 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.38800517 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.38524694 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.38310630 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.36382371 |
| 46 | MP0000716_abnormal_immune_system | 1.34758981 |
| 47 | MP0002933_joint_inflammation | 1.34597669 |
| 48 | MP0009278_abnormal_bone_marrow | 1.34082400 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.32391690 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.29805597 |
| 51 | MP0001853_heart_inflammation | 1.25903356 |
| 52 | MP0003866_abnormal_defecation | 1.24301177 |
| 53 | MP0002060_abnormal_skin_morphology | 1.22229380 |
| 54 | MP0005275_abnormal_skin_tensile | 1.20364961 |
| 55 | MP0001873_stomach_inflammation | 1.19900152 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.19790226 |
| 57 | MP0003075_altered_response_to | 1.19639371 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.19076212 |
| 59 | MP0002722_abnormal_immune_system | 1.18532911 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.17610099 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.17610099 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.16917097 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.16369923 |
| 64 | MP0005360_urolithiasis | 1.15187329 |
| 65 | MP0005166_decreased_susceptibility_to | 1.15108788 |
| 66 | MP0002429_abnormal_blood_cell | 1.14276958 |
| 67 | MP0003252_abnormal_bile_duct | 1.14031797 |
| 68 | MP0005023_abnormal_wound_healing | 1.13269046 |
| 69 | MP0008469_abnormal_protein_level | 1.10271726 |
| 70 | MP0003448_altered_tumor_morphology | 1.09571020 |
| 71 | MP0004883_abnormal_blood_vessel | 1.08822590 |
| 72 | MP0003045_fibrosis | 1.08633158 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.08567808 |
| 74 | MP0005164_abnormal_response_to | 1.07871741 |
| 75 | MP0009840_abnormal_foam_cell | 1.07757874 |
| 76 | MP0004381_abnormal_hair_follicle | 1.07346871 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.06678084 |
| 78 | MP0000858_altered_metastatic_potential | 1.06436691 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.05147221 |
| 80 | MP0002796_impaired_skin_barrier | 1.04552521 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 1.03828271 |
| 82 | MP0000609_abnormal_liver_physiology | 1.02980465 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.00515868 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.99253738 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.98540054 |
| 86 | MP0009764_decreased_sensitivity_to | 0.96083842 |
| 87 | MP0005310_abnormal_salivary_gland | 0.96065850 |
| 88 | MP0003828_pulmonary_edema | 0.95783574 |
| 89 | MP0010678_abnormal_skin_adnexa | 0.94708793 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.93248033 |
| 91 | MP0002396_abnormal_hematopoietic_system | 0.93196228 |
| 92 | MP0008004_abnormal_stomach_pH | 0.91776227 |
| 93 | MP0001851_eye_inflammation | 0.91685614 |
| 94 | MP0000249_abnormal_blood_vessel | 0.91534405 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.91351262 |
| 96 | MP0000343_altered_response_to | 0.91324259 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.90598611 |
| 98 | MP0002254_reproductive_system_inflammat | 0.90249731 |
| 99 | MP0000383_abnormal_hair_follicle | 0.89582258 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.87943010 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.85196754 |
| 102 | MP0001958_emphysema | 0.84174704 |
| 103 | MP0000604_amyloidosis | 0.83608434 |
| 104 | MP0000490_abnormal_crypts_of | 0.82483580 |
| 105 | MP0003091_abnormal_cell_migration | 0.82238267 |
| 106 | MP0005409_darkened_coat_color | 0.81646518 |
| 107 | MP0009931_abnormal_skin_appearance | 0.81523242 |
| 108 | MP0002009_preneoplasia | 0.80271878 |
| 109 | MP0009763_increased_sensitivity_to | 0.79348238 |
| 110 | MP0000377_abnormal_hair_follicle | 0.79125803 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.78950943 |
| 112 | MP0003795_abnormal_bone_structure | 0.78851856 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.78348758 |
| 114 | MP0001191_abnormal_skin_condition | 0.78097400 |
| 115 | MP0005365_abnormal_bile_salt | 0.78011269 |
| 116 | MP0002098_abnormal_vibrissa_morphology | 0.77617674 |
| 117 | MP0003195_calcinosis | 0.75098595 |
| 118 | MP0003279_aneurysm | 0.74933122 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74304261 |
| 120 | MP0003690_abnormal_glial_cell | 0.71986775 |
| 121 | MP0009115_abnormal_fat_cell | 0.71029764 |
| 122 | MP0001663_abnormal_digestive_system | 0.70634526 |
| 123 | MP0001348_abnormal_lacrimal_gland | 0.69857496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.66251306 |
| 2 | Hematochezia (HP:0002573) | 3.29289771 |
| 3 | Spontaneous hematomas (HP:0007420) | 3.26249735 |
| 4 | T lymphocytopenia (HP:0005403) | 3.21311974 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 3.18655420 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.15178771 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 2.97440625 |
| 8 | Nasal polyposis (HP:0100582) | 2.94167398 |
| 9 | Pustule (HP:0200039) | 2.94020900 |
| 10 | Chronic otitis media (HP:0000389) | 2.93658508 |
| 11 | Myocardial infarction (HP:0001658) | 2.88593236 |
| 12 | Recurrent viral infections (HP:0004429) | 2.86973162 |
| 13 | Recurrent abscess formation (HP:0002722) | 2.81444218 |
| 14 | Recurrent bronchitis (HP:0002837) | 2.77992486 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77218137 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77218137 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77218137 |
| 18 | Polycythemia (HP:0001901) | 2.68020563 |
| 19 | Recurrent fungal infections (HP:0002841) | 2.67520330 |
| 20 | Inflammation of the large intestine (HP:0002037) | 2.67402516 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66906640 |
| 22 | Obstructive lung disease (HP:0006536) | 2.66906640 |
| 23 | Agammaglobulinemia (HP:0004432) | 2.65232658 |
| 24 | Myositis (HP:0100614) | 2.63127336 |
| 25 | Pulmonary infiltrates (HP:0002113) | 2.61926207 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.61173381 |
| 27 | Increased IgE level (HP:0003212) | 2.60476239 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 2.59611008 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.59483770 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59216748 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55668253 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55668253 |
| 33 | Colitis (HP:0002583) | 2.53017945 |
| 34 | Abnormality of T cells (HP:0002843) | 2.50109517 |
| 35 | Cellulitis (HP:0100658) | 2.44177860 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41358064 |
| 37 | IgM deficiency (HP:0002850) | 2.37751263 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.37502138 |
| 39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37502138 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.36383818 |
| 41 | Papilloma (HP:0012740) | 2.35016301 |
| 42 | Verrucae (HP:0200043) | 2.35016301 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34844048 |
| 44 | Vasculitis (HP:0002633) | 2.32946111 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.31434689 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 2.27564356 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.26140623 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26140623 |
| 49 | Fatigue (HP:0012378) | 2.24535336 |
| 50 | Stomatitis (HP:0010280) | 2.23896772 |
| 51 | Malnutrition (HP:0004395) | 2.22493037 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.21760600 |
| 53 | Chronic diarrhea (HP:0002028) | 2.19849076 |
| 54 | Gingival bleeding (HP:0000225) | 2.18970374 |
| 55 | Encephalitis (HP:0002383) | 2.18842648 |
| 56 | Arterial thrombosis (HP:0004420) | 2.17132875 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.16623289 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.14411518 |
| 59 | Orchitis (HP:0100796) | 2.12603885 |
| 60 | IgA deficiency (HP:0002720) | 2.10210634 |
| 61 | Abnormality of the peritoneum (HP:0002585) | 2.09181856 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.05895532 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.05057403 |
| 64 | Meningitis (HP:0001287) | 2.04531084 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.03839861 |
| 66 | Viral hepatitis (HP:0006562) | 2.03669437 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02738774 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02738774 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02738774 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.01721890 |
| 71 | Emphysema (HP:0002097) | 2.01675789 |
| 72 | Keratoconjunctivitis (HP:0001096) | 1.99377493 |
| 73 | Increased IgM level (HP:0003496) | 1.99005482 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98895276 |
| 75 | Loss of speech (HP:0002371) | 1.98836957 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 1.98248730 |
| 77 | Abnormality of macrophages (HP:0004311) | 1.97083682 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 1.95952854 |
| 79 | Abnormal platelet function (HP:0011869) | 1.95708014 |
| 80 | Impaired platelet aggregation (HP:0003540) | 1.95708014 |
| 81 | Pulmonary embolism (HP:0002204) | 1.95674064 |
| 82 | Urticaria (HP:0001025) | 1.95592430 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 1.95514956 |
| 84 | Esophageal varix (HP:0002040) | 1.95162253 |
| 85 | Thin bony cortex (HP:0002753) | 1.92163810 |
| 86 | Recurrent skin infections (HP:0001581) | 1.90874363 |
| 87 | Recurrent sinusitis (HP:0011108) | 1.90355318 |
| 88 | Thick nail (HP:0001805) | 1.87396792 |
| 89 | Hypoglycemic coma (HP:0001325) | 1.86973227 |
| 90 | Persistence of primary teeth (HP:0006335) | 1.86561137 |
| 91 | Gangrene (HP:0100758) | 1.85862055 |
| 92 | Amyloidosis (HP:0011034) | 1.85555224 |
| 93 | Osteomyelitis (HP:0002754) | 1.85038806 |
| 94 | Skin ulcer (HP:0200042) | 1.83515547 |
| 95 | Ulnar bowing (HP:0003031) | 1.82056727 |
| 96 | Increased mean platelet volume (HP:0011877) | 1.82024080 |
| 97 | Glomerulopathy (HP:0100820) | 1.81902594 |
| 98 | Rectal prolapse (HP:0002035) | 1.81849802 |
| 99 | Vertebral compression fractures (HP:0002953) | 1.81781306 |
| 100 | Epistaxis (HP:0000421) | 1.81683151 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 1.81445779 |
| 102 | Microcytic anemia (HP:0001935) | 1.81077764 |
| 103 | Deep venous thrombosis (HP:0002625) | 1.80684729 |
| 104 | Aortic aneurysm (HP:0004942) | 1.80607184 |
| 105 | Sepsis (HP:0100806) | 1.80517537 |
| 106 | Spondylolisthesis (HP:0003302) | 1.80470120 |
| 107 | Petechiae (HP:0000967) | 1.80468894 |
| 108 | Lymphopenia (HP:0001888) | 1.79997765 |
| 109 | Conjunctival hamartoma (HP:0100780) | 1.79911585 |
| 110 | Recurrent pneumonia (HP:0006532) | 1.79666599 |
| 111 | Increased density of long bones (HP:0006392) | 1.79339961 |
| 112 | Recurrent lower respiratory tract infections (HP:0002783) | 1.79298634 |
| 113 | Skin rash (HP:0000988) | 1.78414716 |
| 114 | Abnormal foot bone ossification (HP:0010675) | 1.78408412 |
| 115 | Hypochromic anemia (HP:0001931) | 1.78183729 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77611306 |
| 117 | Purpura (HP:0000979) | 1.76167860 |
| 118 | Arthralgia (HP:0002829) | 1.75793374 |
| 119 | Periodontitis (HP:0000704) | 1.75560418 |
| 120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.74891823 |
| 121 | Poikilocytosis (HP:0004447) | 1.74700161 |
| 122 | Xerostomia (HP:0000217) | 1.74636054 |
| 123 | Gingivitis (HP:0000230) | 1.74060688 |
| 124 | Xanthomatosis (HP:0000991) | 1.74037864 |
| 125 | Acrocyanosis (HP:0001063) | 1.73945920 |
| 126 | Milia (HP:0001056) | 1.73620467 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.73619534 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.73301573 |
| 129 | Premature loss of primary teeth (HP:0006323) | 1.71508897 |
| 130 | Subacute progressive viral hepatitis (HP:0006572) | 1.71399884 |
| 131 | Ventricular tachycardia (HP:0004756) | 1.70554773 |
| 132 | Peritonitis (HP:0002586) | 1.70408810 |
| 133 | Hyporeflexia of lower limbs (HP:0002600) | 1.68562288 |
| 134 | Chest pain (HP:0100749) | 1.68291014 |
| 135 | Hemoptysis (HP:0002105) | 1.67332007 |
| 136 | Eosinophilia (HP:0001880) | 1.67244655 |
| 137 | Mitral valve prolapse (HP:0001634) | 1.64899754 |
| 138 | Optic neuritis (HP:0100653) | 1.63813334 |
| 139 | Retrobulbar optic neuritis (HP:0100654) | 1.63813334 |
| 140 | Restrictive lung disease (HP:0002091) | 1.63512625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.97489044 |
| 2 | PRPF4B | 3.75242792 |
| 3 | TRIB3 | 3.58635111 |
| 4 | MAP4K1 | 3.23670302 |
| 5 | ERN1 | 2.77699699 |
| 6 | MAP3K13 | 2.53985913 |
| 7 | STK10 | 2.39021366 |
| 8 | PKN2 | 2.35646323 |
| 9 | TYK2 | 2.18206550 |
| 10 | EPHB1 | 2.10900115 |
| 11 | FGFR4 | 2.00369324 |
| 12 | MAP3K10 | 1.94436801 |
| 13 | LRRK2 | 1.92611163 |
| 14 | TAOK3 | 1.89750105 |
| 15 | TBK1 | 1.88695495 |
| 16 | JAK3 | 1.88435378 |
| 17 | ITK | 1.86318757 |
| 18 | BLK | 1.83637863 |
| 19 | MST4 | 1.78896498 |
| 20 | JAK1 | 1.73780404 |
| 21 | ZAP70 | 1.69688897 |
| 22 | BMPR2 | 1.63928967 |
| 23 | PTK6 | 1.62022314 |
| 24 | FGFR3 | 1.61859115 |
| 25 | TTN | 1.60082645 |
| 26 | TGFBR2 | 1.56404129 |
| 27 | CSK | 1.54219797 |
| 28 | MAP3K14 | 1.52487412 |
| 29 | TRPM7 | 1.52061922 |
| 30 | EEF2K | 1.50297011 |
| 31 | FRK | 1.48692540 |
| 32 | TXK | 1.48607142 |
| 33 | GRK6 | 1.46654981 |
| 34 | IKBKE | 1.43819444 |
| 35 | CDK12 | 1.43673435 |
| 36 | MAP3K3 | 1.36356826 |
| 37 | FES | 1.34857373 |
| 38 | SMG1 | 1.30806714 |
| 39 | RIPK1 | 1.26609483 |
| 40 | MAP2K3 | 1.24886983 |
| 41 | BTK | 1.20617470 |
| 42 | IRAK3 | 1.20406305 |
| 43 | CDC42BPA | 1.19449848 |
| 44 | RPS6KA4 | 1.18409392 |
| 45 | FGR | 1.16776146 |
| 46 | SIK3 | 1.16738902 |
| 47 | JAK2 | 1.14443092 |
| 48 | TAOK2 | 1.11735942 |
| 49 | DMPK | 1.11541419 |
| 50 | TEC | 1.10631624 |
| 51 | KSR2 | 1.08184024 |
| 52 | PRKCH | 1.07378474 |
| 53 | NEK9 | 1.04608197 |
| 54 | HIPK2 | 1.03920780 |
| 55 | NLK | 0.99779281 |
| 56 | KDR | 0.98518740 |
| 57 | IKBKB | 0.98108540 |
| 58 | SIK1 | 0.96042183 |
| 59 | CDK6 | 0.94522944 |
| 60 | SYK | 0.94040259 |
| 61 | EPHA3 | 0.93402172 |
| 62 | PIM1 | 0.92632043 |
| 63 | PDPK1 | 0.91705530 |
| 64 | HCK | 0.91195832 |
| 65 | STK4 | 0.89817992 |
| 66 | STK3 | 0.89645700 |
| 67 | LCK | 0.89240781 |
| 68 | IRAK4 | 0.87777364 |
| 69 | MATK | 0.87510770 |
| 70 | MARK3 | 0.85864859 |
| 71 | CHUK | 0.85787883 |
| 72 | BMX | 0.80986959 |
| 73 | MOS | 0.80571803 |
| 74 | IRAK2 | 0.80012483 |
| 75 | PRKCQ | 0.79904982 |
| 76 | MAPK7 | 0.79496512 |
| 77 | STK24 | 0.78229619 |
| 78 | MAP3K1 | 0.78065876 |
| 79 | PDGFRA | 0.78002019 |
| 80 | MAPK12 | 0.74300862 |
| 81 | MST1R | 0.73504610 |
| 82 | SCYL2 | 0.73444454 |
| 83 | DYRK1B | 0.72986776 |
| 84 | ARAF | 0.72741547 |
| 85 | KIT | 0.72411666 |
| 86 | PDGFRB | 0.72262647 |
| 87 | FLT3 | 0.70730754 |
| 88 | MELK | 0.69741078 |
| 89 | NME2 | 0.68760536 |
| 90 | MAP3K7 | 0.68373132 |
| 91 | CSF1R | 0.64961247 |
| 92 | DDR2 | 0.64898242 |
| 93 | MAPK11 | 0.64008687 |
| 94 | MAP3K6 | 0.63286117 |
| 95 | MARK2 | 0.62474404 |
| 96 | CLK1 | 0.61156488 |
| 97 | PIK3CG | 0.59241665 |
| 98 | MAP3K2 | 0.59183956 |
| 99 | PRKD1 | 0.58868423 |
| 100 | MAP2K2 | 0.57958875 |
| 101 | MAPKAPK3 | 0.56720490 |
| 102 | PTK2 | 0.56549185 |
| 103 | LATS1 | 0.56381348 |
| 104 | NUAK1 | 0.56097481 |
| 105 | FGFR2 | 0.55773030 |
| 106 | TNK2 | 0.55512481 |
| 107 | ICK | 0.55197385 |
| 108 | CAMK1D | 0.54783902 |
| 109 | EGFR | 0.51359736 |
| 110 | MAP3K11 | 0.50253159 |
| 111 | PRKD2 | 0.48549471 |
| 112 | MAP3K8 | 0.47623983 |
| 113 | MAPKAPK2 | 0.47591230 |
| 114 | CDK4 | 0.47571795 |
| 115 | RET | 0.47418916 |
| 116 | MAPK4 | 0.47326269 |
| 117 | LYN | 0.46012710 |
| 118 | INSRR | 0.44245694 |
| 119 | RPS6KC1 | 0.44041620 |
| 120 | RPS6KL1 | 0.44041620 |
| 121 | GSK3A | 0.43446644 |
| 122 | WNK4 | 0.42946649 |
| 123 | MAP3K5 | 0.42784342 |
| 124 | PRKG2 | 0.42553710 |
| 125 | YES1 | 0.41864121 |
| 126 | TAOK1 | 0.41015303 |
| 127 | IRAK1 | 0.40543629 |
| 128 | PDK1 | 0.39466580 |
| 129 | SIK2 | 0.38636687 |
| 130 | ILK | 0.38515998 |
| 131 | ABL1 | 0.37892236 |
| 132 | SGK3 | 0.37655153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.52469623 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23236175 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07845948 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04408174 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01202523 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96791426 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86377230 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82409451 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81473521 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.79809605 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77726009 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77193856 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71473133 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68745719 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.63962907 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.56193534 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51817859 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45422063 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44256835 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39035423 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33150877 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31709986 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30483004 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29955252 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29204644 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26374416 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.24468346 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.22914584 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.22696320 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.20971150 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20858303 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20186903 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19862819 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.19842610 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19624426 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.18064788 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17004624 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12336903 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.12019137 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11908124 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10528308 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.08259844 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08223882 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.08106801 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.07341992 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07290676 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06783727 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.06773452 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06067447 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.05245273 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.03636042 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.02321881 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01601795 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01258288 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 1.00326036 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99681096 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98497853 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.96129547 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.94076862 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90945522 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.90575224 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90563647 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89964832 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.89369795 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88638353 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86873536 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86212094 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.82369573 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.82262441 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80671841 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80400692 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76998243 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76819991 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76772651 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.75784449 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73727713 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72529244 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.71372303 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70806120 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70096708 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70089397 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69744410 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69371934 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67861835 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67199419 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66472305 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.66204411 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65631231 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65420519 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65127588 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.64527855 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64314542 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62715052 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62154526 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61961334 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60028456 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.59535199 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59327300 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59321386 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59058378 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58712282 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58555865 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.57839516 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57101777 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56047341 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55904966 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53036742 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52964102 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52470225 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51598160 |
| 111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49216136 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49092845 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49078720 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48198577 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47665416 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47428942 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46910863 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46774095 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46378532 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45950412 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45391651 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43158487 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42036739 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41840670 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41776178 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39640529 |

